MHRA GPvP Inspectorate Guide to Marketing Authorisation Holder Considerations for Agreements with Pharmacovigilance System Service Providers

Posted by: , Posted on: - Categories: Compliance matters, Good pharmacovigilance practice
A light bulb within a thought bubble

The pharmacovigilance systems of marketing authorisation holders are often dependent on multiple third parties; extensive outsourcing and partnering is a feature of the pharmaceutical industry as much as any other. This blog expands upon the areas identified as problematic for MAHs and service providers and provides points to consider when producing contracts and agreements text.

EU-FDA mutual recognition of inspections of medicines manufacturers enters operational phase

Handshake in front of Usa and Eu flags

Today marks the start of the operational phase of the EU-FDA mutual recognition agreement